Last reviewed · How we verify
NCT05634343
Laughter Therapy and Mindfulness Practices
NA trial testing experimental group 1 in Nurse's Role in 117 participants. Completed in 20 October 2022.
20 April 2022
Quick facts
| Lead sponsor | Nagihan Koroglu Kaba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 117 |
| Start date | 6 September 2021 |
| Primary completion | 20 April 2022 |
| Estimated completion | 20 October 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- experimental group 1
- experimantal group 2
Conditions studied
- Nurse's Role — all drugs for Nurse's Role →
Sponsor
Nagihan Koroglu Kaba
Who can join
Eligibility, any sex, with Nurse's Role. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nurses working by shifts under intense stress and pressure and using complicated technological products- undergo fatigue and attention deficit with the effect of the many negative factors caused by work setting. This threatens patient and staff safety as well as leads to communicational problems, work absenteeism, lowered motivation, inability to control stress and poor work performance and productivity among nurses as well. In this sense; laughter therapy and mindfulness practices may help nurses cope with these problems because some experimental studies proved that both methods showed many benefits in different samples. However; no studies in which these two methods were compared among nurses were encountered. Therefore; the study -being in experimental design and randomized controlled trial- will be undertaken with a total of 111 nurses employed at a university hospital -37 nurses allocated to the experimental 1 group, 37 nurses to the experimental 2 group and 37 nurses to the control group-. First; Computer-Based Sustained Attention Test, the Stroop Test Çapa Version, The Chalder Fatigue Scale (CFQ) and Individual Work Performance Questionnaire will be administered to the nurses of the experimental and control groups as a pre-test. Then; nurses of the experimental 1 group will join sessions of laughter therapy (30-45 minutes twice a week for 8 weeks) and nurses of the experimental 2 group will join sessions of mindfulness practices (45-60 minutes twice a week for 8 weeks) for two months. One month later when the sessions are started, a mid test will be administered and soon after the sessions are completed a post test will be administered to the nurses via Computer-Based Sustained Attention Test, the Stroop Test Çapa Version, The Chalder Fatigue Scale (CFQ) and Individual Work Performance Questionnaire. One month later after the post test; a follow-up will be performed using the same tools. As a result; the effects of both applications on fatigue, attention and performance will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05634343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nurse's Role
Currently open trials in the same condition.
- NCT07109492 — The Role of Mandala Painting Before Surgery · NA · recruiting
- NCT07109557 — The Effect of Baduanjin on Patients Undergoing Knee Replacement Surgery · NA · recruiting
- NCT07171008 — The Effect of Ney Music on Patients Undergoing Lumbar Disc Surgery · NA · recruiting
- NCT06875531 — Perceptions of Student Nurses About Professional Nursing Values of Creative Drama Education · NA · recruiting
- NCT06742827 — Educational Intervention and Adherence · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05634343 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nagihan Koroglu Kaba
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05634343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing